Delivery Order SPE2DB22D2007-SPE2DB25FJ4WN
- Not listed
- The Defense Logistics Agency awarded a $7,434.55 delivery order to AmerisourceBergen Drug Corp on September 7, 2025, for the supply of IC Green 25 mg vials. This is a firm fixed price, competitively awarded contract with a completion date of September 8, 2025, and will be performed in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical, which carries a ceiling value of...
- The Defense Logistics Agency awarded a $6,230.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IC Green 25 mg vials, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $4,515.41 to AmerisourceBergen Drug Corp for IC Green 25 mg vials, with a completion date of September 2, 2025. This is a firm fixed-price delivery order under a competitive contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major healthcare solutions provider for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 4,569,259,256 IC Green 25 mg vials under a firm fixed-price contract valued at $8,018.77. This non-set-aside award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,060.31 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,252.74 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,024.40 to AmerisourceBergen Drug Corp on September 8, 2025, for pharmaceutical and medical supply products under contract number 4569359419. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,776.36 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order valued at $3,770.55 to AmerisourceBergen Drug Corp on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4WNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IC GREEN 25 mg vials valued at $2,450.82 under a firm fixed-price contract type. This non-set-aside award was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this delivery order as a child contract under a larger vehicle supporting the Defense Logistics Agency's medical supply chain operations. This award represents a routine pharmaceutical delivery under AmerisourceBergen Drug Corp's extensive relationship with the Defense Logistics Agency. The contractor maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching procurement vehicle enabling the company to supply pharmaceutical products and medical commodities globally to support military healthcare programs. The short completion window and modest order value reflect the transactional nature of delivery orders issued against this comprehensive pharmaceutical support agreement, demonstrating the contractor's ongoing role in sustaining medical supply availability for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/11/25 |